Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here


Medical Technology and Device News Title

  • June 23, 2017:

    Scott Gottlieb, M.D., Commissioner of Food and Drugs announce on the FDA blog, the FDA announced a new Digital Health Innovation Plan that is focused on fostering innovation at the intersection of medicine and digital health technology. This plan will include a novel, post-market approach to how we intend to regulate these digital medical devices. For example, According to one estimate, last year there were 165,000 health-related apps available for Apple or Android smartphones which generally fall outside the purview of the FDA. However, for apps with multiple functions the issue is less clear.
    FDA, led by Center for Devices and Radiological Health (CDRH, is working to implement the digital health provisions of the 21st Century Cures Act and, in the coming months, will be publishing guidance to further clarify what falls outside the scope of FDA regulation and to explain how the new statutory provisions affect pre-existing FDA policies.Full Story

  • June 23, 2017:

    Cartilage doesn't grow back after injury or overuse, but the team, led by Kyriacos Athanasiou, a professor in the biomedical engineering department at University of California, Davis, have created an artificial version that could replace it. The lab-grown cartilage grown with tension (top) shows similar mechanical and chemical properties to natural cartilage, which allows a person's joints to move smoothly and would have great potential to help people regain mobility.Full Story

  • June 21, 2017:

    Organ-on-chip technology promises to help speed up and improve research on how potential new drugs will interact with the body’s own organs. Additionally, it may alleviate the need for in-animal studies that can be difficult to perform and that too often produce misleading results. Olivier Henry, Ph.D., a Wyss Institute Staff Engineer who was the driving force behind the new Organ Chip designs. “In contrast to past electrode designs, this fixed geometry allows accurate measurements that are fully comparable within and between experiments, and that tell us exactly how tissues like that of lung or gut mature within a channel, keep in shape and break down under the influence of drugs or other manipulations".Full Story

  • June 9, 2017:

    Toyota has announced the strategic goal of creating a system that would predict the occurrence of adverse cardiac events in real time. Kayvan Najarian, Ph.D., director of data science at the Michigan Center for Integrative Research in Critical Care has received a grant from Toyota to fund the necessary research to create a system that could be placed in the vehicle to monitor and predict an adverse cardiac event. The work will use machine-learning models to analyze the data collected from in-hospital and in-vehicle subjects. The research team will then test the system on real-time prediction of cardiac events..Full Story

  • June 8, 2017:

    Massachusetts Institute of Technology (MIT) researchers, collaborating with investigators at Beth Israel Deaconess Medical Center has devised a way to stimulate regions deep within the brain using electrodes placed on the scalp that has proven successful in treating many Parkinson’s disease patients. This approach could make deep brain stimulation noninvasive, less risky, less expensive, and more accessible.Full Story

  • June 6, 2017:

    Rice University and their colleagues at the Texas Heart Institute are introducing a wireless, battery-less pacemaker that can be implanted directly into a patient's heart at the IEEE's International Microwave Symposium (IMS) in Honolulu.
    Designed by computer engineering professor Aydin Babakhani harvests energy wirelessly from radio frequency radiation transmitted by an external battery pack. The pacemaker can be inserted into the heart and powered by a battery pack outside the body, eliminating the need for wire leads, which are infection risks, and no longer needing surgeries to replace the battery.Full Story

  • June 2, 2017:

    Intuitive Surgical, a developer of robotic-assisted, minimally invasive surgery, announced that its da Vinci X Surgical System received FDA clearance in the United States. The da Vinci X System enables optimized, focused-quadrant surgery including procedures like prostatectomy, partial nephrectomy, benign hysterectomy, and sacrocolpopexy. The da Vinci X System will provide surgeons and hospitals with surgery technology at a lower cost. FDA clearance of the da Vinci X System follows CE Mark, which was announced in April.Full Story